tirzepatide surmount-1 weight loss percent 72 weeks Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: (tirzepatide/Zepbound, weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Body composition changes during weight
Pay in 4 interest-free payments of $7.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
























